Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
British Journal of Pharmacology
|
October 11, 2024
Early transtympanic administration of rhBDNF exerts a multifaceted neuroprotective effect against cisplatin-induced hearing loss
Anna Pisani, Rolando Rolesi, Veronica Mohamed-Hizam, et al.
Viruses
|
May 27, 2023
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action
Daniela Iaconis, Francesca Caccuri, Candida Manelfi, et al.
British Journal of Cancer
|
November 17, 2022
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer
Geny Piro, Carmine Carbone, Antonio Agostini, et al.
PNAS Nexus
|
August 21, 2025
Human nerve growth factor delivery to the retina: Quantitative methodology and mathematical modeling in preclinical settings
Simone L Mattioli, Prashant Dogra, Francesco Longobardi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 11, 2023
Ketoprofen, lysine and gabapentin co-crystal magnifies synergistic efficacy and tolerability of the constituent drugs: Pre-clinical evidences towards an innovative therapeutic approach for neuroinflammatory pain
Andrea Aramini, Gianluca Bianchini, Samuele Lillini, et al.
Cell Death & Disease
|
May 25, 2022
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions
Laura Brandolini, Michele d'Angelo, Rubina Novelli, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
British Journal of Pharmacology
|
October 11, 2024
Early transtympanic administration of rhBDNF exerts a multifaceted neuroprotective effect against cisplatin-induced hearing loss
Anna Pisani, Rolando Rolesi, Veronica Mohamed-Hizam, et al.
Viruses
|
May 27, 2023
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action
Daniela Iaconis, Francesca Caccuri, Candida Manelfi, et al.
British Journal of Cancer
|
November 17, 2022
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer
Geny Piro, Carmine Carbone, Antonio Agostini, et al.
PNAS Nexus
|
August 21, 2025
Human nerve growth factor delivery to the retina: Quantitative methodology and mathematical modeling in preclinical settings
Simone L Mattioli, Prashant Dogra, Francesco Longobardi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 11, 2023
Ketoprofen, lysine and gabapentin co-crystal magnifies synergistic efficacy and tolerability of the constituent drugs: Pre-clinical evidences towards an innovative therapeutic approach for neuroinflammatory pain
Andrea Aramini, Gianluca Bianchini, Samuele Lillini, et al.
Cell Death & Disease
|
May 25, 2022
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions
Laura Brandolini, Michele d'Angelo, Rubina Novelli, et al.
Page
of 4